CA2424039A1 - Quantitative digital fluorography and related products and methods - Google Patents
Quantitative digital fluorography and related products and methods Download PDFInfo
- Publication number
- CA2424039A1 CA2424039A1 CA002424039A CA2424039A CA2424039A1 CA 2424039 A1 CA2424039 A1 CA 2424039A1 CA 002424039 A CA002424039 A CA 002424039A CA 2424039 A CA2424039 A CA 2424039A CA 2424039 A1 CA2424039 A1 CA 2424039A1
- Authority
- CA
- Canada
- Prior art keywords
- receptor
- analyte
- image
- solid support
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 58
- 238000003556 assay Methods 0.000 claims abstract description 25
- 239000007850 fluorescent dye Substances 0.000 claims abstract description 8
- 238000012360 testing method Methods 0.000 claims description 36
- 239000012491 analyte Substances 0.000 claims description 33
- 239000000523 sample Substances 0.000 claims description 31
- 239000007787 solid Substances 0.000 claims description 21
- 230000000007 visual effect Effects 0.000 claims description 20
- 239000000427 antigen Substances 0.000 claims description 14
- 102000036639 antigens Human genes 0.000 claims description 14
- 108091007433 antigens Proteins 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 13
- 238000011088 calibration curve Methods 0.000 claims description 11
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 claims description 10
- 230000009871 nonspecific binding Effects 0.000 claims description 8
- 238000005406 washing Methods 0.000 claims description 8
- 210000004027 cell Anatomy 0.000 claims description 7
- 238000011534 incubation Methods 0.000 claims description 7
- 238000004020 luminiscence type Methods 0.000 claims description 6
- 150000007523 nucleic acids Chemical class 0.000 claims description 6
- 102000039446 nucleic acids Human genes 0.000 claims description 6
- 108020004707 nucleic acids Proteins 0.000 claims description 6
- 238000004364 calculation method Methods 0.000 claims description 5
- 230000005284 excitation Effects 0.000 claims description 5
- 238000004422 calculation algorithm Methods 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 4
- 238000010521 absorption reaction Methods 0.000 claims description 3
- 230000003460 anti-nuclear Effects 0.000 claims description 3
- 230000006872 improvement Effects 0.000 claims description 3
- 108060003951 Immunoglobulin Proteins 0.000 claims description 2
- 239000011324 bead Substances 0.000 claims description 2
- 239000012530 fluid Substances 0.000 claims description 2
- 102000018358 immunoglobulin Human genes 0.000 claims description 2
- 239000000725 suspension Substances 0.000 claims description 2
- 238000002493 microarray Methods 0.000 claims 3
- 230000003612 virological effect Effects 0.000 claims 2
- 241000700605 Viruses Species 0.000 claims 1
- 230000000295 complement effect Effects 0.000 claims 1
- 238000003384 imaging method Methods 0.000 claims 1
- 210000004962 mammalian cell Anatomy 0.000 claims 1
- 244000052769 pathogen Species 0.000 claims 1
- 230000001717 pathogenic effect Effects 0.000 claims 1
- 210000001236 prokaryotic cell Anatomy 0.000 claims 1
- 238000000159 protein binding assay Methods 0.000 abstract description 4
- 239000003446 ligand Substances 0.000 abstract description 3
- 230000003381 solubilizing effect Effects 0.000 abstract description 2
- 239000003550 marker Substances 0.000 abstract 2
- 101710125089 Bindin Proteins 0.000 abstract 1
- 108091034117 Oligonucleotide Proteins 0.000 abstract 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 abstract 1
- 238000009396 hybridization Methods 0.000 abstract 1
- 238000003018 immunoassay Methods 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- 239000000975 dye Substances 0.000 description 31
- 238000010790 dilution Methods 0.000 description 13
- 239000012895 dilution Substances 0.000 description 13
- 230000027455 binding Effects 0.000 description 12
- 230000008901 benefit Effects 0.000 description 9
- 210000002966 serum Anatomy 0.000 description 7
- 238000004113 cell culture Methods 0.000 description 6
- 239000013610 patient sample Substances 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 239000011534 wash buffer Substances 0.000 description 4
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000003909 pattern recognition Methods 0.000 description 3
- 238000013207 serial dilution Methods 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 208000023275 Autoimmune disease Diseases 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000003748 differential diagnosis Methods 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 238000007901 in situ hybridization Methods 0.000 description 2
- 238000007899 nucleic acid hybridization Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 208000030507 AIDS Diseases 0.000 description 1
- 241000606161 Chlamydia Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241000701022 Cytomegalovirus Species 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- 208000016604 Lyme disease Diseases 0.000 description 1
- 238000000636 Northern blotting Methods 0.000 description 1
- 102000011931 Nucleoproteins Human genes 0.000 description 1
- 108010061100 Nucleoproteins Proteins 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 201000005485 Toxoplasmosis Diseases 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 210000003855 cell nucleus Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 238000013480 data collection Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 238000002073 fluorescence micrograph Methods 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000012207 quantitative assay Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 201000000596 systemic lupus erythematosus Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/645—Specially adapted constructive features of fluorimeters
- G01N21/6456—Spatial resolved fluorescence measurements; Imaging
- G01N21/6458—Fluorescence microscopy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N15/1468—Optical investigation techniques, e.g. flow cytometry with spatial resolution of the texture or inner structure of the particle
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/02—Devices for withdrawing samples
- G01N1/22—Devices for withdrawing samples in the gaseous state
- G01N1/2247—Sampling from a flowing stream of gas
- G01N1/2252—Sampling from a flowing stream of gas in a vehicle exhaust
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N15/1429—Signal processing
- G01N15/1433—Signal processing using image recognition
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/02—Devices for withdrawing samples
- G01N1/22—Devices for withdrawing samples in the gaseous state
- G01N1/2247—Sampling from a flowing stream of gas
- G01N2001/2264—Sampling from a flowing stream of gas with dilution
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/01—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials specially adapted for biological cells, e.g. blood cells
- G01N2015/019—Biological contaminants; Fouling
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N15/1434—Optical arrangements
- G01N2015/1452—Adjustment of focus; Alignment
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
- G01N35/0099—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor comprising robots or similar manipulators
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Optics & Photonics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US67195600A | 2000-09-27 | 2000-09-27 | |
| US09/671,956 | 2000-09-27 | ||
| PCT/US2001/042219 WO2002027296A1 (en) | 2000-09-27 | 2001-09-17 | Quantitative digital fluorography and related products and methods |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2424039A1 true CA2424039A1 (en) | 2002-04-04 |
Family
ID=24696556
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002424039A Abandoned CA2424039A1 (en) | 2000-09-27 | 2001-09-17 | Quantitative digital fluorography and related products and methods |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1328791A4 (de) |
| AU (1) | AU2001296885A1 (de) |
| CA (1) | CA2424039A1 (de) |
| WO (1) | WO2002027296A1 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102006027516B4 (de) * | 2006-06-09 | 2021-10-07 | Euroimmun Medizinische Labordiagnostika Ag | Verfahren zur Optimierung der automatischen Fluoreszenzmustererkennung in der Immundiagnostik |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4128628A (en) * | 1976-03-12 | 1978-12-05 | University Of Virginia Alumni Patents Foundation | Automated immunoassay |
| US6060598A (en) | 1990-05-15 | 2000-05-09 | Hyperion, Inc. | Fluorescence immunoassays using fluorescent dyes free of aggregation and serum binding |
| US5548661A (en) * | 1991-07-12 | 1996-08-20 | Price; Jeffrey H. | Operator independent image cytometer |
| US5670113A (en) * | 1991-12-20 | 1997-09-23 | Sibia Neurosciences, Inc. | Automated analysis equipment and assay method for detecting cell surface protein and/or cytoplasmic receptor function using same |
| US5732150A (en) * | 1995-09-19 | 1998-03-24 | Ihc Health Services, Inc. | Method and system for multiple wavelength microscopy image analysis |
| US5989835A (en) | 1997-02-27 | 1999-11-23 | Cellomics, Inc. | System for cell-based screening |
| WO2000050903A1 (en) * | 1999-02-24 | 2000-08-31 | Luminex Corporation | Particulate solid phase immobilized protein quantitation |
| AU7131900A (en) * | 1999-06-21 | 2001-01-09 | Cellomics, Inc. | A system for cell-based screening |
-
2001
- 2001-09-17 WO PCT/US2001/042219 patent/WO2002027296A1/en active Application Filing
- 2001-09-17 CA CA002424039A patent/CA2424039A1/en not_active Abandoned
- 2001-09-17 EP EP01977795A patent/EP1328791A4/de not_active Withdrawn
- 2001-09-17 AU AU2001296885A patent/AU2001296885A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1328791A1 (de) | 2003-07-23 |
| AU2001296885A1 (en) | 2002-04-08 |
| WO2002027296A1 (en) | 2002-04-04 |
| EP1328791A4 (de) | 2006-05-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7064813B2 (en) | Apparatus and method for measuring micro area in specimen | |
| US4741043A (en) | Method of and an apparatus for image analyses of biological specimens | |
| US7482167B2 (en) | Microbead-based test methods for fluorescence imaging systems | |
| CA2280154C (en) | Multiple assays of cell specimens | |
| US20090253586A1 (en) | Substrates for multiplexed assays and uses thereof | |
| EP1942346A1 (de) | Mehrfarbige Etiketten | |
| EP2309253A2 (de) | Vorrichtung zum Lesen von durch resonanzlichtgestreute Partikelmarkierungen erzeugten Signalen | |
| CN106841127B (zh) | 空间分辨的配体-受体结合试验 | |
| JPWO2003005005A1 (ja) | 生体試料光学測定方法及び生体試料光学測定装置 | |
| EP1110090B1 (de) | Markierungsmittel mit einer vielzahl von farbtönen | |
| US7361515B2 (en) | Method and test kit for detecting analytes in a sample | |
| MXPA01013398A (es) | Sistema para citometria de escaneo laser de microvolumen. | |
| JP2021189183A (ja) | 情報処理装置、生体試料解析方法、生体試料検出装置、および生体試料検出システム | |
| JP2001272404A (ja) | 蛍光相関分光法による抗原抗体反応 | |
| CA2424039A1 (en) | Quantitative digital fluorography and related products and methods | |
| WO2002073198A2 (en) | Non-separation assay and system using opaque particles | |
| JP3686713B2 (ja) | 走査型細胞測定装置 | |
| EP2515271B1 (de) | Verfahren zur Analyse von Reagenzkügelchen | |
| JP7077992B2 (ja) | 核酸配列計測用デバイス、核酸配列計測方法、および核酸配列計測装置 | |
| WO1999045366A9 (en) | Optical imaging system for diagnostics | |
| CN117471094A (zh) | 一种基于共聚焦拉曼成像的超灵敏侧向流免疫层析试纸条 | |
| EP2535862A1 (de) | Verfahren zur Analyse von Reagenzkügelchen | |
| CN105548129A (zh) | 一种基于单个荧光分子漂白成像检测分子/离子的方法 | |
| JP2004132992A (ja) | 多数の微量蛍光を測定する方法 | |
| TWI226437B (en) | Image display type biochip instrument |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Discontinued |